Medicure, Inc. (NASDAQ:MCUJF) | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
Medicure, Inc.

BRIEF

published on 11/18/2024 at 23:05, 2 days 11 hours ago

Medicure to Present Q3 2024 Financial Results Amid Board Changes

Financial Results Conference Call Q3 2024 Board Resignation Medicure
PRESS RELEASE

published on 11/18/2024 at 23:00, 2 days 11 hours ago

Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member
Medicure Inc. announces 2024 Q3 Financial Results conference call on November 26, 2024. Board member resigns. Company specializes in pharmaceuticals & healthcare products

Conference Call Pharmaceuticals Medicure Inc. Healthcare Products 2024 Q3 Financial Results
BRIEF

published on 10/25/2024 at 00:05, 27 days 10 hours ago

Medicure Reaches Settlement in Product Development and Supply Contract

Pharmaceuticals Product Development Healthcare Products Medicure Settlement
PRESS RELEASE

published on 10/25/2024 at 00:00, 27 days 10 hours ago

Medicure Announces Positive Settlement of Product Development and Supply Contracts
Medicure Inc. settles a product development and supply contract with a third party, receiving €1.5 million. Details remain confidential. Company focuses on pharmaceuticals and healthcare products in the U.S. market

Pharmaceuticals Medicure Inc. Product Development Healthcare Products Supply Contract
BRIEF

published on 08/14/2024 at 23:35, 3 months 6 days ago

Medicure Completes Acquisition of Intellectual Property from CanAm Bioresearch

Intellectual Property CanAm Bioresearch Medicure Acquisition Therapeutic Development Pharmaceutical Assets
PRESS RELEASE

published on 08/14/2024 at 23:30, 3 months 6 days ago

Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual Property
Medicure Inc. acquires intellectual property assets of CanAm Bioresearch Inc. related to new chemical entities for therapeutic use. Agreement terms and related party transaction details provided

Medicure Inc. New Chemical Entities Therapeutic Use CanAm Bioresearch Inc. Intellectual Property Assets
BRIEF

published on 08/14/2024 at 23:05, 3 months 6 days ago

Medicure Reports Financial Results for Quarter Ended June 30, 2024

Financial Results Marley Drug Medicure AGGRASTAT ZYPITAMAG
PRESS RELEASE

published on 08/14/2024 at 23:00, 3 months 6 days ago

Medicure Reports Financial Results for Quarter Ended June 30, 2024
Medicure Inc. reports Q2 2024 financial results: net revenue down, EBITDA negative, net loss recorded. AGGRASTAT and ZYPITAMAG sales impacted. Analyst call on Aug 15, 2024

Financial Results EBITDA Medicure Inc. Net Loss Q2 2024
BRIEF

published on 06/24/2024 at 23:05, 4 months 26 days ago

Medicure Announces Acquisition Agreement with CanAm Bioresearch Inc.

Pharmaceuticals Intellectual Property Asset Purchase Medicure CanAm Bioresearch
PRESS RELEASE

published on 06/24/2024 at 23:00, 4 months 26 days ago

Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property
Medicure Inc. announces asset purchase agreement with CanAm Bioresearch for acquisition of patent and intellectual property related to new chemical entities for therapeutic use

Medicure Inc. Asset Purchase Agreement CanAm Bioresearch New Chemical Entities Therapeutic Use

Accesswire

Published on 11/21/2024 at 10:03, 50 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 53 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 53 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 18 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 28 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 23 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 48 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 51 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 53 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 53 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 55 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 33 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 8 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 8 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE